WO2006087039A1 - Composition d'herbes medicinales antivirale a large spectre - Google Patents

Composition d'herbes medicinales antivirale a large spectre Download PDF

Info

Publication number
WO2006087039A1
WO2006087039A1 PCT/EP2005/050696 EP2005050696W WO2006087039A1 WO 2006087039 A1 WO2006087039 A1 WO 2006087039A1 EP 2005050696 W EP2005050696 W EP 2005050696W WO 2006087039 A1 WO2006087039 A1 WO 2006087039A1
Authority
WO
WIPO (PCT)
Prior art keywords
virus
general accepted
symptoms
monoterpene
outbreak
Prior art date
Application number
PCT/EP2005/050696
Other languages
English (en)
Inventor
Antonia Rodriguez-Gonzalez
Original Assignee
Propharex Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Propharex Sa filed Critical Propharex Sa
Priority to PCT/EP2005/050696 priority Critical patent/WO2006087039A1/fr
Publication of WO2006087039A1 publication Critical patent/WO2006087039A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • Medical Problem 01 Subjects having following symptoms : Blisters anywhere on the body, but especially near the mouth or genital areas. Some subjects experienced prodromal symptoms: tingling, pain, burning, or itching in the area a few days before the blisters appear.
  • molluscum contagiosum also called water wart skin disease caused by the molluscum contagiosum virus (or MCV), a DNA poxvirus. Symptoms disappear within 6 months to 2 years. Medical treatments for this condition include cryosurgery, where liquid nitrogen is used to freeze and destroy the lesion, as well as scraping them off with a curette. Side-effects from these treatments include permanent discoloration and scarring.
  • Medical Problem 16 Measles , also known as rubeola, a common disease caused by a virus of the genus Morbillivirus [47] Medical Problem 17 : Subjects manifesting following symptoms : face pain, swelling of the parotid glands (neck swelling) (in 60%-70% of cases), fever, headache, sore throat, swelling of the temples or jaw (temporomandibular area), Additional symptoms in males that may be associated with this disease (in 20 to 30% of cases): testicular pain, testicular enlargement, scrotal swelling.
  • Enterovirus are the second most common viral infectious agents in humans (after the rhinoviruses) [59] Medical Problem 23 : Subjects manifesting following symptoms : Fever, fatigue, muscle or joint pain, loss of appetite, mild to severe nausea and vomiting, yellow eyes and skin ('jaundice'), bloated or swollen stomach [60] Diagnose Medical Problem 23 : Hepatitis B the most common serious liver infection in the world. It is caused by the hepatitis B virus that attacks the liver. The virus is transmitted through blood and infected bodily fluids.
  • Medical Problem 24 Subjects manifesting following symptoms : Jaundice, fatigue, abdominal pain, loss of appetite, nausea, vomiting, joint pain, dark (tea colored) urine [62] Diagnose Medical Problem 24 : Hepatitis D a liver disease caused by the hepatitis D virus (HDV), a defective virus that needs the hepatitis B virus to exist.
  • HDV hepatitis D virus
  • Said common composition is derived through extraction of plants preferably from the following plant families, indicated by the part of the plant used, its specific chemical composition and Major component:.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention se rapporte à un remède antiviral à large spectre à base d'herbes médicinales qui est sans danger et d'une efficacité remarquable contre les infections et syndromes viraux aigus. Le remède de l'invention peut être administré par voie topique, orale, rectale, vaginale, nasale, par l'inhalation d'aérosols ou par voie parentérale. La composition de l'invention permet de réduire de manière drastique les symptômes causés par presque tous les virus connus à une vitesse qui dépasse de loin les temps de récupération généralement acceptés tels que mesurés selon les procédés d'observation médicale généralement acceptés. La composition de l'invention inhibe également la prolifération et/ou l'activité virale dans presque toutes les infections virales aiguës et empêche les épidémies répétées de syndromes viraux.
PCT/EP2005/050696 2005-02-17 2005-02-17 Composition d'herbes medicinales antivirale a large spectre WO2006087039A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/050696 WO2006087039A1 (fr) 2005-02-17 2005-02-17 Composition d'herbes medicinales antivirale a large spectre

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/050696 WO2006087039A1 (fr) 2005-02-17 2005-02-17 Composition d'herbes medicinales antivirale a large spectre

Publications (1)

Publication Number Publication Date
WO2006087039A1 true WO2006087039A1 (fr) 2006-08-24

Family

ID=35064712

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/050696 WO2006087039A1 (fr) 2005-02-17 2005-02-17 Composition d'herbes medicinales antivirale a large spectre

Country Status (1)

Country Link
WO (1) WO2006087039A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009153791A1 (fr) * 2008-06-19 2009-12-23 Avivi-Easy-Life Ltd. Composés terpénoïdes antiviraux
WO2015072852A1 (fr) * 2013-11-13 2015-05-21 Rjg Developments B.V. Traitement d'éruptions de l'infection par le virus de l'herpès à l'aide de valériane
RU2655524C1 (ru) * 2017-06-01 2018-05-28 Всеволод Иванович Киселёв Натуральное вирулицидное средство и вирулицидный препарат на его основе (варианты)
CN109864988A (zh) * 2019-04-18 2019-06-11 中国科学院武汉病毒研究所 佛手柑素和/或蔓荆子黄素的应用和应用其的产品
CN114259489A (zh) * 2022-01-24 2022-04-01 中国科学院武汉病毒研究所 佛手柑素在制备治疗或预防新型冠状病毒感染的抗病毒制品中的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002007744A1 (fr) * 2000-07-20 2002-01-31 Anne Marie Pierrette Giraud Association d'huiles essentielles et applications therapeutiques
WO2002062361A1 (fr) * 2001-02-06 2002-08-15 Cherbuliez Theodore Composition antivirale contenant de la propolis et des huiles essentielles
ES2173816A1 (es) * 2001-04-11 2002-10-16 Merino Antonio Monino Composicion de un producto para la eliminacion de toda clase de virus y bacterias.
FR2830198A1 (fr) * 2001-09-28 2003-04-04 Jean Pierre Willem Compositions pharmaceutiques comprenant des huiles essentielles et leurs utilisations
WO2003049726A1 (fr) * 2001-12-07 2003-06-19 Eden Research Plc Prophylaxie et traitement des infections respiratoires avec des compositions contenant du terpene

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002007744A1 (fr) * 2000-07-20 2002-01-31 Anne Marie Pierrette Giraud Association d'huiles essentielles et applications therapeutiques
WO2002062361A1 (fr) * 2001-02-06 2002-08-15 Cherbuliez Theodore Composition antivirale contenant de la propolis et des huiles essentielles
ES2173816A1 (es) * 2001-04-11 2002-10-16 Merino Antonio Monino Composicion de un producto para la eliminacion de toda clase de virus y bacterias.
FR2830198A1 (fr) * 2001-09-28 2003-04-04 Jean Pierre Willem Compositions pharmaceutiques comprenant des huiles essentielles et leurs utilisations
WO2003049726A1 (fr) * 2001-12-07 2003-06-19 Eden Research Plc Prophylaxie et traitement des infections respiratoires avec des compositions contenant du terpene

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MINAMI MASATO ET AL.: "The inhibitory effect of essential oils on herpes simplex virus type-1 replication in vitro", MICROBIOLOGY AND IMMUNOLOGY, vol. 47, no. 9, 2003, pages 681 - 684, XP009055977 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009153791A1 (fr) * 2008-06-19 2009-12-23 Avivi-Easy-Life Ltd. Composés terpénoïdes antiviraux
WO2015072852A1 (fr) * 2013-11-13 2015-05-21 Rjg Developments B.V. Traitement d'éruptions de l'infection par le virus de l'herpès à l'aide de valériane
RU2655524C1 (ru) * 2017-06-01 2018-05-28 Всеволод Иванович Киселёв Натуральное вирулицидное средство и вирулицидный препарат на его основе (варианты)
CN109864988A (zh) * 2019-04-18 2019-06-11 中国科学院武汉病毒研究所 佛手柑素和/或蔓荆子黄素的应用和应用其的产品
CN109864988B (zh) * 2019-04-18 2021-07-30 中国科学院武汉病毒研究所 佛手柑素和/或蔓荆子黄素的应用和应用其的产品
CN114259489A (zh) * 2022-01-24 2022-04-01 中国科学院武汉病毒研究所 佛手柑素在制备治疗或预防新型冠状病毒感染的抗病毒制品中的应用

Similar Documents

Publication Publication Date Title
CN102085311B (zh) 预防或治疗感冒和/或流行性感冒的中药组合物及其制备方法和用途
WO2006087039A1 (fr) Composition d'herbes medicinales antivirale a large spectre
WO2011023013A1 (fr) Médicament pour la dissolution et l’élimination de verrues et d’excroissances constituées de protéine et ses utilisations
Fang et al. Hydroquinone inhibits PRV infection in neurons in vitro and in vivo
Zhang et al. Potential of green tea EGCG in neutralizing SARS-CoV-2 Omicron variant with greater tropism toward the upper respiratory tract
CN104288727B (zh) 一种小儿风寒感冒保健专用的中药复方制剂
García-Salazar et al. Broad antiviral spectrum of glycyrrhizic acid for human and veterinary medicine: reality or fiction?
CN113855654A (zh) 一种预防和治疗冠状病毒感染的组合物
CN108186718A (zh) 一种预防及抑制hpv病毒的妇科喷剂
Jassey et al. Antiviral effects of black seeds: Effect on COVID-19
CN105796538A (zh) 白藜芦醇及其类似物作为hiv潜伏病毒库激活剂的应用
Stefanou et al. Pomegranate as an anti-viral agent and immune system stimulant
CN102370971A (zh) 一种治疗鸡痘的复方蜂胶组合物及其制备方法
TW202202159A (zh) 組合物，製作方法和用於治療病毒感染，包括冠狀病毒感染和流感，以及用於表面消毒的產品
CN101721604B (zh) 一种中药组合物在制备治疗手口足病药物中的应用
Li et al. Anti-virus effect of traditional Chinese medicine Yi-Fu-Qing granule on acute respiratory tract infections.
CN104906206A (zh) 一种抗鸭和兔病毒性肝损伤的中药复方
Yadav Conventional Therapeutic Drugs and Traditional Herbal Medicine in Prevention and Treatment of Novel Corona Virus (COVID-19): An Update
Mahajan et al. Traditional Ayurvedic Formulation in the Management of COVID-19
CN114796365B (zh) 一种抑制新冠病毒进入细胞的中药制剂
Cui et al. Caffeic acid phenethyl ester: an effective antiviral agent against porcine reproductive and Respiratory Syndrome Virus
CN112294868B (zh) 用于病毒灭活与卫生消毒、激活机体免疫能力产生的药物
Fasogbon et al. Positive therapeutic role of some selected food and plant on covid-19: a review
WO2022078563A1 (fr) Nouveau composé mixte pour le traitement et la protection contre le (corona)virus de la covid-19
Yan et al. A Randomized, Blinded, Double Controlled Study of the Effects of Modified Ma Xing Shi Gan Tang on Mortality, Recovery and Serum Superoxide Dismutase, Glutathione Peroxidase and Malondialdehyde in Chickens with Infectious Bronchitis.

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 05737472

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 05737472

Country of ref document: EP

Kind code of ref document: A1

WWW Wipo information: withdrawn in national office

Ref document number: 5737472

Country of ref document: EP